GlassScriptPhysician profile
Anthony Alan Hilliard
NPI 1841262623
$28,706.36
in general payments reported to CMS, 2019-2025
8 companies · $698 in 2025
The $698 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.81 · 2020: $39.12 · 2021: $12.27 · 2022: $6,227 · 2023: $3,446 · 2024: $18K · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $17K · Travel and Lodging: $3,853 · Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $17,400.00 |
| Travel and Lodging | $3,852.74 |
| Food and Beverage | $1,096.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $27,537.93 | 2019-2025 | Impella |
| Abbott Laboratories | $567.42 | 2022-2024 | Ultreon, Mitraclip, Aveir |
| Penumbra, INC. | $234.54 | 2022 | |
| Edwards Lifesciences Corporation | $172.20 | 2022 | |
| Biotronik INC. | $144.02 | 2022 | |
| Medtronic, INC. | $33.71 | 2025 | Symplicity G3 |
| Sanofi-Aventis U.S. LLC | $16.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Hilliard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.